Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TRVI
TRVI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TRVI News
Trevi Therapeutics Q1 2026 Earnings Call Insights
May 06 2026
seekingalpha
Trevi Therapeutics Q1 Earnings Report Analysis
May 05 2026
seekingalpha
Trevi Therapeutics Prices $150 Million Public Offering Amid Bullish Market Sentiment
Apr 17 2026
stocktwits
Trevi Therapeutics Prices Public Offering at $13 per Share
Apr 17 2026
NASDAQ.COM
Trevi Therapeutics Prices $150 Million Public Offering of Common Stock
Apr 17 2026
Newsfilter
Trevi Therapeutics Raises $150 Million in Public Offering
Apr 17 2026
Yahoo Finance
TREVI THERAPEUTICS INC ANNOUNCES $150 MILLION GROSS PROCEEDS FROM 11.6 MILLION SHARE OFFERING PRICED AT $13.00 PER SHARE
Apr 17 2026
moomoo
TREVI THERAPEUTICS REVEALS PRICING FOR $150 MILLION UNDERWRITTEN COMMON STOCK OFFERING
Apr 17 2026
moomoo
Trevi Therapeutics Announces $150M Public Offering
Apr 16 2026
seekingalpha
Trevi Therapeutics to Participate in Multiple Healthcare Conferences
Apr 01 2026
Newsfilter
Trevi Therapeutics (TRVI) Earnings Transcript
Mar 18 2026
NASDAQ.COM
Trevi Therapeutics Reports Narrowed Losses and Trial Updates
Mar 18 2026
NASDAQ.COM
Trevi Therapeutics Reports Key Insights from Q4 2025 Earnings Call
Mar 18 2026
seekingalpha
Trevi Therapeutics Advances Clinical Trials with Positive Data
Mar 18 2026
Yahoo Finance
Trevi Therapeutics Q4 Earnings Beat Expectations
Mar 17 2026
seekingalpha
Multiple Companies Set to Report Earnings
Mar 17 2026
NASDAQ.COM
Show More News
